Form 4 for TMCI TREACE MEDICAL CONCEPTS, INC.
Accepted 2022-03-10 00:00:00 ET · period of report 2022-03-08 · accession 0001567619-22-006732 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-03-10 | 2022-03-08 | TMCI | Lubben Terry W. | SVP, Ops | P - Purchase | $18.62 | +2,500 | 5,850 | +75% | +$46.5K |
| D | 2022-03-10 | 2022-03-08 | TMCI | Lubben Terry W. | SVP, Ops | A - Grant | $0.00 | +3,350 | 3,350 | New | $0 |
| D | 2022-03-10 | 2022-03-08 | TMCI | Lubben Terry W. | SVP, Ops | A - Grant | $0.00 | +25.8K | 25.8K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-03-08 | P | A | 2,500 | $18.62 | 5,850 | D | — | — | (F3) The price reported in Column 4 is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $18.347 to $18.65 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. (F2) Includes 3,350 RSUs. |
| 2 | Common | Common Stock | 2022-03-08 | A | A | 3,350 | $0.00 | 3,350 | D | — | — | (F1) Represents restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of issuer's Common Stock for each RSU upon vesting. The RSUs vest in equal annual installments over 4 years, commencing on March 8, 2023 with the last installment on March 8, 2026? subject to Reporting Person's providing continued service to Issuer through each vesting date. (F2) Includes 3,350 RSUs. |
| 3 | Derivative | Stock Option (Right to Buy) | 2022-03-08 | A | A | 25,800 | $0.00 | 25,800 | D | $19.15 · — to 2032-03-08 | 25,800 Common Stock | (F4) The stock option will vest in equal annual installments over 4 years, commencing on March 8, 2023 with the last installment on March 8, 2026; subject to Reporting Person's providing continued service to Issuer through each vesting date. |